These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6576114)

  • 1. Interactions of ergot compounds with dopamine receptors and endocrine functions.
    Flückiger E
    J Neural Transm Suppl; 1983; 18():189-204. PubMed ID: 6576114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropharmacological intervention on the pituitary-hypothalamic relationship.
    Tuomisto J
    Ann Clin Res; 1978; 10(3):120-32. PubMed ID: 31130
    [No Abstract]   [Full Text] [Related]  

  • 3. Action of dopamine receptor agonists and antagonists, and a serotonin antagonist on prolactin release from isolated rat pituitary cell columns [proceedings].
    Delitala G; Stubbs WA; Yeo T; Jones A; Thorner MO; Besser GM
    J Endocrinol; 1979 May; 81(2):121P. PubMed ID: 458305
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological and biochemical evidence for the dopamine agonistic effect of bromocriptine.
    Fuxe K; Fredholm BB; Ogren SO; Agnati LF; Hökfelt T; Gustafsson JA
    Acta Endocrinol Suppl (Copenh); 1978; 216():27-56. PubMed ID: 347864
    [No Abstract]   [Full Text] [Related]  

  • 5. Endocrine profile of a specific prolactin inhibitor: Br-ergocryptine (CB 154). A preliminary report.
    Del Pozo E; Friesen H; Burmeister P
    Schweiz Med Wochenschr; 1973 Jun; 103(23):847-8. PubMed ID: 4351250
    [No Abstract]   [Full Text] [Related]  

  • 6. Central neurotransmitters and the secretion of prolactin, GH, LH and TSH.
    Krulich L
    Annu Rev Physiol; 1979; 41():603-15. PubMed ID: 35093
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of pituitary tumor growth and function by ergot alkaloids.
    MacLeod RM; Lehmeyer JE
    Cancer Res; 1973 Apr; 33(4):849-55. PubMed ID: 4348776
    [No Abstract]   [Full Text] [Related]  

  • 8. [Age and the body's endocrine situation].
    Nikitin VN
    Usp Sovrem Biol; 1977; 84(5):257-71. PubMed ID: 208321
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple CNS receptor interactions of ergot alkaloids: affinity and intrinsic activity analysis in in vitro binding systems.
    U'Prichard DC
    Adv Biochem Psychopharmacol; 1980; 23():103-15. PubMed ID: 6249089
    [No Abstract]   [Full Text] [Related]  

  • 10. Endocrine profile and therapeutic employment of a new prolactin-lowering drug, metergoline.
    Ferrari C; Reschini E; Peracchi M; Crosignani PG
    Gynecol Obstet Invest; 1980; 11(1):1-16. PubMed ID: 6248438
    [No Abstract]   [Full Text] [Related]  

  • 11. [Age and aspects of the body's endocrine situation].
    Nikitin VN
    Usp Sovrem Biol; 1977; 84(2):257-71. PubMed ID: 203135
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroendocrine approach to headache.
    Polleri A; Nappi G; Masturzo P; Martignoni E; Murialdo G; Bono G; Testa E; Savoldi F
    Adv Neurol; 1982; 33():173-82. PubMed ID: 6119893
    [No Abstract]   [Full Text] [Related]  

  • 13. Interactions between hypothalamic and peripheral hormones in the control of prolactin secretion.
    Ferland L; Labrie F; Kelly PA; Raymond V
    Fed Proc; 1980 Sep; 39(11):2917-22. PubMed ID: 7409210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel fish hypothalamic neuropeptides stimulate the release of gonadotrophins and growth hormone from the pituitary of sockeye salmon.
    Amano M; Moriyama S; Iigo M; Kitamura S; Amiya N; Yamamori K; Ukena K; Tsutsui K
    J Endocrinol; 2006 Mar; 188(3):417-23. PubMed ID: 16522722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary hormones and ergot alkaloids.
    Müller EE; Cocchi D; Panerai AE; Gil-Ad I; Locatelli V; Mantegazza P
    Pharmacology; 1978; 16 Suppl 1():63-77. PubMed ID: 205891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of angiotensin II on in vivo and in vitro release of anterior pituitary hormones in the female rat.
    Steele MK; Negro-Vilar A; McCann SM
    Endocrinology; 1981 Sep; 109(3):893-9. PubMed ID: 7262024
    [No Abstract]   [Full Text] [Related]  

  • 17. Tachykinins and the control of prolactin secretion.
    Debeljuk L; Lasaga M
    Peptides; 2006 Nov; 27(11):3007-19. PubMed ID: 16930771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the neuroendocrine role of serotonin.
    Jørgensen HS
    Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alpha-methyldopa and its metabolites on prolactin release: in vivo and in vitro studies.
    Wiggins JF; Sved AF; Fernstrom JD
    J Pharmacol Exp Ther; 1980 Feb; 212(2):304-8. PubMed ID: 6766188
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of cyclosporine on circulating levels of prolactin, LH, FSH, TSH and GH in chronic hyperprolactinemic male rats.
    Lafuente A; Alvarez-Demanuel E; Blanco A; García-Bonacho M; Esquifino AI
    Rev Esp Fisiol; 1996 Sep; 52(3):161-6. PubMed ID: 8974151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.